Insider Transactions in Q4 2021 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2021
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
39,700
+27.92%
|
$0
$0.67 P/Share
|
Dec 22
2021
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
2,607
-1.35%
|
$224,202
$86.45 P/Share
|
Dec 22
2021
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,607
+3.83%
|
$18,249
$7.22 P/Share
|
Dec 21
2021
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
25,104
-15.42%
|
$2,133,840
$85.83 P/Share
|
Dec 21
2021
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,104
+22.22%
|
$175,728
$7.22 P/Share
|
Dec 20
2021
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
4,289
-6.4%
|
$364,565
$85.2 P/Share
|
Dec 20
2021
|
Giuseppe Ciaramella President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,289
+6.01%
|
$30,023
$7.22 P/Share
|
Oct 06
2021
|
John M. Evans CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-2.54%
|
$1,660,000
$83.97 P/Share
|
Oct 06
2021
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
27,700
-0.66%
|
$2,299,100
$83.96 P/Share
|
Oct 06
2021
|
John M. Evans CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,700
+2.54%
|
$27,700
$1.03 P/Share
|